Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

38 Special: How FDA Shot Down Drug Shortages In 2010

Executive Summary

By working with sponsors, FDA averted 38 drug shortages in 2010, the agency reports.

You may also be interested in...



FDA’s Drug Shortage Reg Adds More Manufacturers, Products To Notification List

Interim final rule redefines the terms “sole manufacturer” and “discontinuance.”

FDA’s Drug Shortage Prevention Tally: 96 Saves In Six Weeks

At Senate hearing, the agency says an executive order has helped spur notifications, while the GAO suggests Congress require manufacturers to tell FDA about anything that could affect the drug supply. Reimbursement changes will not solve the shortage problem, an HHS official argues.

FDA's Drug Shortages Strategy Focuses On Prevention, Not "Empire Building"

FDA would like additional funding for a number of its programs, but it does not appear that the agency will be pushing to expand its drug shortage team.

Topics

UsernamePublicRestriction

Register

OM004078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel